The Manufacturers Life Insurance Company Boosts Position in Astera Labs, Inc. $ALAB

The Manufacturers Life Insurance Company raised its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 79.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 538,205 shares of the company’s stock after acquiring an additional 238,911 shares during the period. The Manufacturers Life Insurance Company’s holdings in Astera Labs were worth $58,987,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Eurizon Capital SGR S.p.A. acquired a new stake in Astera Labs during the 4th quarter worth about $18,708,000. Swedbank AB raised its stake in shares of Astera Labs by 76.8% during the 4th quarter. Swedbank AB now owns 78,140 shares of the company’s stock valued at $12,999,000 after buying an additional 33,940 shares during the last quarter. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. acquired a new position in shares of Astera Labs in the 4th quarter valued at about $499,000. Revere Asset Management Inc acquired a new position in shares of Astera Labs in the 4th quarter valued at about $589,000. Finally, Banque Cantonale Vaudoise lifted its holdings in shares of Astera Labs by 85.9% in the 1st quarter. Banque Cantonale Vaudoise now owns 6,990 shares of the company’s stock valued at $766,000 after buying an additional 3,229 shares during the period. 60.47% of the stock is owned by hedge funds and other institutional investors.

Astera Labs Stock Down 4.0%

ALAB stock opened at $249.74 on Thursday. The company’s 50-day simple moving average is $359.85 and its 200-day simple moving average is $228.24. Astera Labs, Inc. has a 52-week low of $97.89 and a 52-week high of $499.48. The firm has a market cap of $42.81 billion, a P/E ratio of 168.74, a PEG ratio of 3.01 and a beta of 3.66.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, beating the consensus estimate of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The firm had revenue of $308.36 million during the quarter, compared to analyst estimates of $292.19 million. During the same quarter in the previous year, the business earned $0.33 EPS. Astera Labs’s revenue for the quarter was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, analysts anticipate that Astera Labs, Inc. will post 1.86 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

ALAB has been the topic of several analyst reports. Barclays raised their target price on Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a report on Monday, July 20th. Bank of America boosted their price target on Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a report on Tuesday, June 23rd. Evercore restated an “outperform” rating and issued a $297.00 price objective on shares of Astera Labs in a research report on Tuesday, May 19th. Morgan Stanley raised their price objective on shares of Astera Labs from $210.00 to $240.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 6th. Finally, Susquehanna lifted their target price on shares of Astera Labs from $155.00 to $230.00 and gave the company a “neutral” rating in a report on Wednesday, May 6th. Thirteen investment analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $282.00.

Insider Buying and Selling

In other news, Director Stefan A. Dyckerhoff sold 3,505 shares of the company’s stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $450.00, for a total transaction of $1,577,250.00. Following the completion of the transaction, the director directly owned 57,466 shares of the company’s stock, valued at $25,859,700. This represents a 5.75% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 8,491 shares of the stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $458.38, for a total value of $3,892,104.58. Following the transaction, the director owned 286,863 shares in the company, valued at $131,492,261.94. This trade represents a 2.87% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 1,676,845 shares of company stock valued at $444,928,806 in the last 90 days. Corporate insiders own 10.40% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.